Table 1.
Characteristics of patients registered for pre-ART care
| Characteristics | In care (n=864) N (col %) |
Lost (n=307) N (col %) |
P values* | Tracked (n=195) N (col %) |
Not tracked (n=112) N (col %) |
P values† | Found (n=118) N (col %) |
Not found (n=77) N (col %) |
P values‡ |
| Sex | 0.17 | 0.97 | 0.84 | ||||||
| Male | 258 (30.5%) | 109 (35.5%) | 69 (35.4%) | 72 (64.3%) | 41 (34.7%) | 28 (36.4%) | |||
| Female | 588 (69.5%) | 198 (64.5%) | 126 (64.6%) | 40 (35.7%) | 77 (65.3%) | 49 (63.6%) | |||
| Location | 0.02 | 0.13 | 0.38 | ||||||
| Urban sites | 718 (84.9%) | 207 (67.4%) | 116 (59.5%) | 91 (81.3%) | 66 (55.9%) | 50 (64.9%) | |||
| Rural sites | 128 (15.1%) | 100 (32.6%) | 79 (40.5%) | 21 (18.8%) | 52 (44.1%) | 27 (35.1%) | |||
| Age in years | 0.15 | 0.25 | 0.44 | ||||||
| <20 | 27 (3.2 %) | 18 (5.9 %) | 14 (7.3 %) | 4 (3.6%) | 10 (8.7 %) | 4 (5.3 %) | |||
| 20–29 | 415 (49.2%) | 158 (52.1%) | 96 (50.3%) | 62 (55.4%) | 53 (46.1%) | 43 (56.6%) | |||
| 30–39 | 266 (31.6%) | 86 (28.4%) | 58 (30.4%) | 28 (25%) | 35 (30.4%) | 23 (30.3%) | |||
| 40–49 | 91 (10.8%) | 35 (11.6%) | 22 (11.5%) | 13 (11.6%) | 16 (13.9%) | 6 (7.9 %) | |||
| 50+ | 44 (5.2 %) | 6 (2.0 %) | 1 (0.5 %) | 5 (4.5%) | 1 (0.9 %) | 0 (0.0 %) | |||
| Missing | 3 | 4 | 4 | 0 | 3 | 1 | |||
| CD4 count cell | 0.08 | 0.07 | 0.27 | ||||||
| 350–499 | 137 (18.0%) | 35 (15.6%) | 21 (16.5%) | 14 (14.4%) | 13 (17.8%) | 8 (14.8%) | |||
| 500–749 | 376 (49.4%) | 100 (44.6%) | 53 (41.7%) | 47 (48.5%) | 34 (46.6%) | 19 (35.2%) | |||
| 750+ | 248 (32.6%) | 89 (39.7%) | 53 (41.7%) | 36 (37.1%) | 26 (35.6%) | 27 (50.0%) | |||
| Median (IQR) | 644 (525‒812) | 654 (540‒892) | 659 (553‒918) | 648 (534‒862) | 640 (553‒885) | 734 (565‒946) | |||
| Missing | 85 | 83 | 68 | 15 | 45 | 23 | |||
| Weight (kg) | 0.27 | 0.53 | 0.10 | ||||||
| <50 | 98 (12.5%) | 36 (15.4%) | 19 (14.0%) | 17 (17.3%) | 9 (11.4%) | 10 (17.5%) | |||
| 50 to <60 | 285 (36.5%) | 87 (37.2%) | 48 (35.3%) | 39 (39.8%) | 28 (35.4%) | 20 (35.1%) | |||
| 60 to <70 | 235 (30.0%) | 76 (32.5%) | 45 (33.1%) | 31 (31.6%) | 22 (27.8%) | 23 (40.4%) | |||
| 70+ | 164 (21.0%) | 35 (15.0%) | 24 (17.6%) | 11 (11.2%) | 20 (25.3%) | 4 (7.0%) | |||
| Median (IQR) | 60 (52‒66) | 59 (52‒65) | 60 (52‒65.5) | 58 (52‒65) | 60 (53‒70) | 59 (51‒62) | |||
| Missing | 64 | 73 | 59 | 14 | 39 | 20 |
*P value comparing those in care and lost, using Rao-Scott correction to χ2 test to account for clustered sampling. Individuals with missing values excluded from comparison.
†P value comparing those selected for tracing and not selected, calculated as described in footnote *.
‡P value comparing those successfully traced and those not found, calculated as described in footnote *.
ART, antiretroviral treatment.